Headlines

Dolly Parton’s 30 Greatest Songs

How do we count the ways in which we will always love her — do we go from 9 to 5,000? Here’s a compromise: We’ve selected 30 of Dolly Parton’s greatest songs, from among hundreds. This task is taken on knowing that among the omissions will be cuts that are most meaningful to

Iran says US sanctions will achieve nothing

Iran's president insisted on Wednesday that the United States would achieve nothing with its new sanctions campaign after Washington laid out plans to collapse the country's economy. Almost six months into their war, the two sides are locked in a stalemate, with Iran keeping

Trump sends Saudi Arabia nuclear deal to Congress

President Trump’s administration sent a nuclear cooperation agreement with Saudi Arabia that would allow the kingdom to enrich uranium to Congress this week, kick-starting a congressional review process required under the Atomic Energy Act. However, President Trump's

When fruits and veggies are scarce, monkeys hunt for meat

Capuchin monkeys hunt prey when fruits and vegetables become scarce, potentially mirroring the habits of human ancestors, according to a study published in PLOS One by Susana Carvalho (Gorongosa National Park, Mozambique), Noemi Spagnoletti (Sapienza University of Rome, Italy)

Tiny atomic changes could lead to smarter wireless technology

Researchers at Queen Mary University of London have shown that making extremely small changes to the structure of a material can dramatically improve its ability to respond to electrical signals. Published recently in Science Advances, the breakthrough could help create a new

Michael Nau Announces New Album Popfly: Hear The Title Track

The veteran indie singer-songwriter Michael Nau, who you may know from Page France and Cotton Jones, is readying his latest solo LP. Popfly will be launched into the world in October, at the height of the baseball playoffs, which feels appropriate. Along with the announcement,

Music

FDA approves groundbreaking new pancreatic cancer drug

The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms of cancer. The once-daily pill, called daraxonrasib and manufactured by Revolution